Professor Øivind Torkildsen discusses the increasing importance of MRI scanning in monitoring multiple sclerosis disease activity.
"I think we see that MRI scanning is increasingly important. In the old days, that means about 10 years ago, we used to say that “we don’t treat MRI pictures, we treat patients”. But now we know that we can do both. We know that all of these new MRI lesions (new gadolinium lesions and new T2 lesions) represent areas not only with demyelination but also with irreversible brain damage. I think MRI has revolutionised the way we follow up and treat patients."